Skip to content

AcrySof® IQ PanOptix® Toric Trifocal IOL TFNT50 (REF TFNT50U135)Recalls & reported problems

Alcon Laboratories, Inc. · AcrySof® IQ PanOptix® Toric Trifocal intraocular lenses (IOLs) are ultraviolet absorbing and blue light filtering foldable multifocal IOLs · Class 3 · Implant

All models of AcrySof IQ PanOptix Toric Trifocal IOL (165)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00380652416450), received between May 13, 2021 and May 13, 2021 — classified as 1 malfunction.

The most frequently reported specific device problem is “Malposition of Device” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Malposition of Device1

Patient problems

  • Blurred Vision1
  • Visual Impairment1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionMay 13, 2021Malposition of Device; Malposition of Device

    A CUSTOMER REPORTED THAT AFTER IMPLANTATION OF AN INTRAOCULAR LENS (IOL) THE IOL HAS ROTATED 40 DEGREES AND THE VISION SLOWLY BECAME BLURRY AND HAZY SINCE POST OPERATIVE 6 MONTHS. ADDITIONAL INFORMATION WAS REQUESTED.

    Patient problems: Blurred Vision; Visual Impairment

    MAUDE report 11818822 ↗

Other Lens, multifocal intraocular devices

All Lens, multifocal intraocular devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page